Lansoprazole
These highlights do not include all the information needed to use LANSOPRAZOLE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for LANSOPRAZOLE DELAYED-RELEASE CAPSULES.LANSOPRAZOLE delayed-release capsules, for oral useInitial U.S. Approval: 1995
427cf924-be17-47dc-8f77-115fa2f3fe17
HUMAN PRESCRIPTION DRUG LABEL
Mar 31, 2022
Teva Pharmaceuticals USA, Inc.
DUNS: 001627975
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lansoprazole
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Lansoprazole
Product Details
FDA regulatory identification and product classification information